Alkaline surge drives margins past guidance, Jammu ramp underway

Delivered ₹407.7 Cr exactly, +9.0% YoY confirmed in results

Q1 EBITDA margin 15.1%, significantly exceeds prior guidance despite 17% zinc inflation

Segment performance aligns with disclosed growth rates and premiumization narrative

Market share trajectory confirmed; target 25–30% in 2 years from 18% current

Facility live from May 29; gross margin benefit claimed but not yet realized; pre-op costs capitalized

Q1 delivered 15.1% vs FY26 target 11.5%. Pricing actions + efficiencies overcame 17% zinc inflation.

Now 18% (from 3% in 30 months). Explicit 25–30% target in 2 years. Jammu facility live to support scale.

Breakeven Q1 after 18–20 months erosion. Emergency LEDs, insulation tapes gaining traction.

Management deferred long-term targets, requesting 1–2 quarters. Shows caution despite Q1 beat.

Growth is alkaline-driven (18% now, 20%+ CAGR), not carbon-zinc (flat 58%). Alkaline device trade-up story, not substitution.

10% gross margin uplift on alkaline. Operating margin depends on overhead allocation. Did not commit to specific OPM.

Device trade-up + penetration offsetting cannibalism. Zinc volumes flat; alkaline +19–23% CAGR. No cannibalism for 1–2 years.

Domestic alkaline growth + white-label/export opportunities. Only alkaline plant in India = structural advantage.

Purely operational (pricing + efficiencies), no one-offs. Will adjust pricing if zinc inflation persists.

Speculative; no information on competitor moves. Brands will fill vacated space if it occurs.

Early stage (6 months old), targeting 1–2% share, looking to 2x FY26 levels. Sourced, not manufactured.

No movement yet; advanced discussions. NCSS scheme: 3× GST refund on ₹90–95 Cr capex over 10 years.

Requesting 1–2 more quarters before formalizing targets. Want execution to parallel guidance.

Capitalized until May 29; added to assets. Post-May 29, expenses to P&L.

Breakeven Q1 after 18–20 months erosion. Cost softening emerging. Watch Q2–Q3.

Similar momentum expected. 25–30% target in 2 years from 18% now, brand + device penetration driven.

₹165 Cr debt now. With ₹200+ Cr Jammu capex yet to yield, debt-free in 4–5 quarters.

Total battery ₹4,100 Cr (MRP). Alkaline ₹550 Cr now, 20% CAGR. Could reach ₹1,400+ Cr in 5Y.

Commodity linkage like any FMCG. Took price increases Q4 + Q1. Will take more if needed; weekly monitoring.

Management requesting 1–2 more quarters to formalize. Alkaline 20%+ CAGR is proxy growth driver.

Q1 delivered 15.1% EBITDA margin, exceeding guidance by 360 bps. Pricing actions + efficiencies supporting margins.

Facility live May 29. Pre-op costs capitalized. Ramp-up to peak capacity expected 12–18 months.

Zinc $3,500/ton (+17% vs <$3,000 last year). Further spikes could overwhelm pricing power if consumer demand softens.

₹90–95 Cr capex invested; facility started May 29. Claimed 10% gross margin uplift pending 100M+ unit scale. Execution delays or sub-target margins could hurt ROI.

Lighting just reached Q1 breakeven after 18–20 months erosion. Fragmented, competitive market. Profitability hinges on emerging sub-segments (emergency LEDs, accessories).

CCI hearing late September 2026 on potential fine (~₹150 Cr if ruled against). EPR compliance cost and structure unclear; awaiting regulatory clarity.

Alkaline 20%+ CAGR while zinc flat. No cannibalization observed yet (device trade-up driver, not substitution). But risk rises at high alkaline saliency.